Verve Therapeutics, Inc. (VERV) Depreciation USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Verve Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2024.
  • Verve Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $1.63 M, a 44.8% increase year-over-year.
  • Verve Therapeutics, Inc. Depreciation for the twelve months ending March 31, 2024 was $5.96 M, a 74.4% increase year-over-year.
  • Verve Therapeutics, Inc. annual Depreciation for 2023 was $5.46 M, a 94.5% increase from 2022.
  • Verve Therapeutics, Inc. annual Depreciation for 2022 was $2.8 M, a 82.7% increase from 2021.
  • Verve Therapeutics, Inc. annual Depreciation for 2021 was $1.54 M, a 15.6% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5.96 M $1.63 M +$505 K +44.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $5.46 M $1.52 M +$592 K +64% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $4.86 M $1.47 M +$757 K +106% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $4.11 M $1.34 M +$689 K +106% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.42 M $1.13 M +$613 K +119% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $2.8 M $925 K +$502 K +119% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $2.3 M $717 K +$305 K +74% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $2 M $648 K +$248 K +62% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.75 M $514 K +$214 K +71.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $1.54 M $423 K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $412 K -$188 K -31.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $400 K +$100 K +33.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $300 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $600 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $300 K Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.